Butterfly Network, Inc. has made headlines with a recent filing indicating that its President and CEO, Joseph DeVivo, plans to sell 90,600 shares of common stock. This move is significant as it reflects the company's ongoing strategies in the X-ray apparatus industry, which is characterized by innovation and competition.
Background
Butterfly Network, Inc. operates in the X-ray apparatus and tubes industry, classified under SIC code 3844. The company is listed on the NYSE under the ticker symbol BFLY. As a smaller reporting company, Butterfly Network has been active in the market, with several recent filings that highlight its business activities and financial performance.
What the Filing Says
The filing, submitted on October 30, 2026, details that DeVivo acquired the shares as part of his equity compensation on July 2, 2026. The approximate sale date for the shares is also noted as October 30, 2026. According to the filing, the aggregate market value of the shares to be sold is $634,200.
Impact
This sale may affect various stakeholders, including investors and employees, as it reflects the leadership's confidence in the company's future. The filing indicates that DeVivo has no other securities to report sold in the past three months, suggesting this transaction is a significant move for him.
What's Next
The filing does not say what happens next.
Read Next
Mirum Pharmaceuticals reports stock sale by former officer
Basswood Financial Fund sells shares of Regional Management Corp.
Basswood Financial Fund Files to Sell Shares in Regional Management
HCA Healthcare Officer Jon M. Foster Files to Sell Shares
Regional Management Corp. Sees Shareholder Stock Sale
Wampler Kira Scherer Reports Stock Transactions for Doximity










